DE69516867T2 - Piperazinderivate als 5 ht1a antagonisten - Google Patents

Piperazinderivate als 5 ht1a antagonisten

Info

Publication number
DE69516867T2
DE69516867T2 DE69516867T DE69516867T DE69516867T2 DE 69516867 T2 DE69516867 T2 DE 69516867T2 DE 69516867 T DE69516867 T DE 69516867T DE 69516867 T DE69516867 T DE 69516867T DE 69516867 T2 DE69516867 T2 DE 69516867T2
Authority
DE
Germany
Prior art keywords
piperazine derivatives
ht1a antagonists
hydrogen
compounds
ht1a
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69516867T
Other languages
English (en)
Other versions
DE69516867D1 (de
Inventor
Ian Brightwell
Gerard Kelly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Application granted granted Critical
Publication of DE69516867D1 publication Critical patent/DE69516867D1/de
Publication of DE69516867T2 publication Critical patent/DE69516867T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Hydrogenated Pyridines (AREA)
DE69516867T 1994-06-03 1995-06-01 Piperazinderivate als 5 ht1a antagonisten Expired - Fee Related DE69516867T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9411099A GB9411099D0 (en) 1994-06-03 1994-06-03 Piperazine derivatives
PCT/GB1995/001263 WO1995033743A1 (en) 1994-06-03 1995-06-01 Piperazine derivatives as 5ht1a antagonists

Publications (2)

Publication Number Publication Date
DE69516867D1 DE69516867D1 (de) 2000-06-15
DE69516867T2 true DE69516867T2 (de) 2000-11-02

Family

ID=10756114

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69516867T Expired - Fee Related DE69516867T2 (de) 1994-06-03 1995-06-01 Piperazinderivate als 5 ht1a antagonisten

Country Status (25)

Country Link
US (1) US5723464A (de)
EP (1) EP0763031B1 (de)
JP (1) JPH10500989A (de)
KR (1) KR100359393B1 (de)
CN (2) CN1048985C (de)
AT (1) ATE192744T1 (de)
AU (1) AU680147B2 (de)
BR (1) BR9507910A (de)
CA (1) CA2191871C (de)
CZ (1) CZ287381B6 (de)
DE (1) DE69516867T2 (de)
DK (1) DK0763031T3 (de)
ES (1) ES2145275T3 (de)
FI (1) FI114985B (de)
GB (1) GB9411099D0 (de)
GR (1) GR3033449T3 (de)
HU (1) HUT76466A (de)
IL (1) IL113967A (de)
MX (1) MX9605915A (de)
NZ (2) NZ287498A (de)
PT (1) PT763031E (de)
RU (1) RU2165933C2 (de)
SK (1) SK281418B6 (de)
WO (1) WO1995033743A1 (de)
ZA (1) ZA954525B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
PT763024E (pt) * 1994-06-03 2002-11-29 Wyeth John & Brother Ltd Novos processos e intermediarios para a preparacao de derivados de piperazina
CA2194984C (en) * 1994-07-26 2002-07-02 John Eugene Macor 4-indole derivatives as serotonin agonists and antagonists
US5519025A (en) * 1995-04-10 1996-05-21 American Home Products Corporation 4-indolylpiperazinyl derivatives
US5486518A (en) * 1995-04-10 1996-01-23 American Home Products Corporation 4-indolylpiperazinyl derivatives
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
IT1282705B1 (it) * 1996-02-28 1998-03-31 Recordati Chem Pharm Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria
DE19615232A1 (de) * 1996-04-18 1997-10-23 Merck Patent Gmbh Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten
DE19725664A1 (de) 1997-06-18 1998-12-24 Merck Patent Gmbh 3-Benzylpiperidine
US6399614B1 (en) 1997-08-01 2002-06-04 Recordati S.A. Chemical And Pharmaceutical Company 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
JP2001512110A (ja) * 1997-08-01 2001-08-21 レコルダチ エッセ．ア．，ケミカル アンド ファーマシューティカル カンパニー １，４−ジ置換ピペラジン
IT1293804B1 (it) 1997-08-01 1999-03-10 Recordati Chem Pharm Diarilalchilpiperazine attive sulle basse vie urinarie
IT1293807B1 (it) * 1997-08-01 1999-03-10 Recordati Chem Pharm Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico
US6271234B1 (en) 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
US6376494B1 (en) 1998-06-15 2002-04-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
EP1087954A1 (de) * 1998-06-15 2001-04-04 American Home Products Corporation Cycloalkyl-substituiertte aryl-piperazine, piperidine und tetrahydropyridine als serotonergische agente
US20060287335A1 (en) 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
EP1367053A4 (de) * 2001-02-27 2005-08-03 Kaneka Corp Verfahren zur herstellung optisch aktiver n-aryl-1-amino-2-propanolderivate
ES2283762T3 (es) * 2002-03-12 2007-11-01 Wyeth Preparacion de acido n1-(2'-piridil)-1,2-propanodiaminosulfamico y su uso en la sintesis de piperazinas biologicamente activas.
US7361773B2 (en) 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
AU2003220110B2 (en) 2002-03-12 2009-04-09 Wyeth Process for making chiral 1,4-disubstituted piperazines
RU2315762C2 (ru) * 2002-03-12 2008-01-27 Уайт Способ синтеза хиральных n-арилпиперазинов
US7091349B2 (en) 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
CN100436448C (zh) * 2003-06-11 2008-11-26 惠氏公司 二环吲哚基衍生物以及其作为5-羟色胺能活性剂的应用
US7179813B2 (en) 2003-06-11 2007-02-20 Wyeth Bicyclic indolyl derivatives and methods for their use as serotonergic agents
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
PE20080332A1 (es) * 2006-06-09 2008-05-05 Wyeth Corp Metodos para mejoramiento de funcion cognitiva
WO2015188085A1 (en) 2014-06-06 2015-12-10 Flexus Biosciences, Inc. Immunoregulatory agents
UY36390A (es) * 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
AR102537A1 (es) 2014-11-05 2017-03-08 Flexus Biosciences Inc Agentes inmunomoduladores
CA2964276A1 (en) 2014-11-05 2016-05-12 Flexus Biosciences, Inc. Immunoregulatory agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
EP0395312B1 (de) * 1989-04-22 1999-05-12 JOHN WYETH & BROTHER LIMITED Piperazin-Derivate
GB9021535D0 (en) * 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
GB9300195D0 (en) * 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives

Also Published As

Publication number Publication date
SK281418B6 (sk) 2001-03-12
CZ350796A3 (en) 1997-06-11
EP0763031A1 (de) 1997-03-19
GR3033449T3 (en) 2000-09-29
IL113967A (en) 1999-03-12
US5723464A (en) 1998-03-03
PT763031E (pt) 2000-10-31
AU680147B2 (en) 1997-07-17
CA2191871A1 (en) 1995-12-14
CZ287381B6 (en) 2000-11-15
SK154196A3 (en) 1997-08-06
WO1995033743A1 (en) 1995-12-14
CN1149873A (zh) 1997-05-14
CN1093122C (zh) 2002-10-23
MX9605915A (es) 1997-12-31
ZA954525B (en) 1996-12-02
ATE192744T1 (de) 2000-05-15
KR970703333A (ko) 1997-07-03
GB9411099D0 (en) 1994-07-27
DK0763031T3 (da) 2000-08-14
CN1227841A (zh) 1999-09-08
ES2145275T3 (es) 2000-07-01
HU9603315D0 (en) 1997-01-28
HUT76466A (en) 1997-09-29
FI114985B (fi) 2005-02-15
RU2165933C2 (ru) 2001-04-27
BR9507910A (pt) 1997-08-12
FI964815A0 (fi) 1996-12-02
IL113967A0 (en) 1995-10-31
NZ331452A (en) 2000-01-28
DE69516867D1 (de) 2000-06-15
CA2191871C (en) 2004-09-21
FI964815A (fi) 1996-12-02
EP0763031B1 (de) 2000-05-10
AU2623095A (en) 1996-01-04
CN1048985C (zh) 2000-02-02
JPH10500989A (ja) 1998-01-27
NZ287498A (en) 1998-10-28
KR100359393B1 (ko) 2003-01-24

Similar Documents

Publication Publication Date Title
ATE192744T1 (de) Piperazinderivate als 5 ht1a antagonisten
IL116122A0 (en) Intermediates to heterocyclic-cyclic amine derivatives
AU3345595A (en) 3-benzoyl benzofuran derivatives as thyroid hormone antagonists
YU35697A (en) Substituted 6,6-hetero-bicyclic derivatives
AP2002002637A0 (en) Novel piperazine
DK0894084T3 (da) Kanelsyrederivater og deres anvendelse som integrinantagonister
CO5271691A1 (es) Nuevos compuestos
JO2321B1 (en) 4-phenyl-pyridine derivatives
ES2104509A1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
ES2104370T3 (es) Derivados de (arilalquilaminobencil)aminopropionamidas sustituidas, su preparacion y utilizacion.
DK0804186T3 (da) Indolditerpenalkaloidforbindelser
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
PT1049672E (pt) Derivados de azetidinocarboxamida para o tratamento de disturbios do snc
PT1049670E (pt) Derivados de azetidinocarboxamida para o tratamento de perturbacoes do snc
ES2101620A1 (es) Nuevo compuesto derivado del cromeno.
YU104092A (sh) NEUROLEPTIČNI 2-SUPSTITUISANI PERHIDRO-1-H-PIRIDO(1,2-a) PIRAZINI
ES2148745T3 (es) Derivados de piperidina usados como diureticos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee